The first FDA approved new metal in 30 years, Molybdenum-Rhenium (MoRe), for the treatment of midfoot/forefoot fractures and fusions
Tuesday, March 18, 2025, 8:00 PM - 9:00 PM EDT
Category: Live Webinar
Tuesday, March 18, 2025 8pm ET / 7pm CT / 6pm MT / 5pm PT The first FDA approved new metal in 30 years, Molybdenum-Rhenium (MoRe), for the treatment of midfoot/forefoot fractures and fusionsSpeaker: Vilayvanh Saysoukha, DPM, MS, FASPS, FACPM
This live activity is supported through an educational grant from MiRus.
ASPS is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. ASPS has approved this activity for a maximum of 1 continuing education contact hour.
If your organization is interested in supporting a future educational activity, please contact us at [email protected].
Contact: [email protected] |